National Center for Occupational Health and Infection Control Report issue

Government

Organization Overview

First Clinical Trial
2012
NCT01673425
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (1)

live attenuated influenza virus vaccine (Flumist) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1